16:33 EST VYNE Therapeutics files to sell 39.27M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VYNE:
- VYNE Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
- VYNE Therapeutics expects cash to fund operations through 2025
- VYNE Therapeutics reports Q3 EPS ($201) vs. ($2.94) last year
- VYNE Therapeutics to host virtual research and development day
- VYNE Therapeutics Announces Closing of Previously Announced Private Placement of $88.2 Million